EFFECT OF ARAGVADHADYAM TAILAM AND DHATRI KHADIR KWATH ON VITILIGO

A PHARMACEUTICO-CLINICAL STUDY OF ARAGVADHADYAM TAILAM AND DHATRI KHADIR KWATH ON SHVITRA WITH SPECIAL REFRENCE TO VITILIGO

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037519

Enrollment

Registered

2021-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing for trial, having signs and symptoms (classical along with some modern parameters).

Exclusion criteria

Exclusion criteria: Patients suffering from AIDS, Cancer, TB, Cardiac complications, patients of Sprue disease, Malabsorption, HB% below 7gm/dl, pregnant women. Vitiligo patches that rapidly spread and become associated with redness, blister formation, itching during therapy or as such.

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptoms of Shvitra.Timepoint: 90 days	—

Secondary

Measure	Time frame
Improvement in signs and symptoms of Shvitra.Timepoint: Evaluation will be done after 90 days	—

Countries

India

Contacts

Public ContactDR NEETU SINGH

goverment ayurvedic college,patna

singhneetu17@gmail.com7091141115

Outcome results